Space Force general says success of private companies like SpaceX helps U.S. secure the space domain
- Gen. John Raymond said the renewed interest in space has led to an explosion of recruitment at the U.S. Space Force, the Pentagon's youngest branch.
- The Space Force has increasingly looked to partner with the private sector as companies and investors pour into the space industry.
- The Pentagon is closely watching the progress of rocket builders like Rocket Lab, Astra and Virgin Orbit, in addition to SpaceX.
WASHINGTON – The nation's top general leading the U.S. military mission in space said Wednesday that he is excited about Wall Street and billionaire investment in the space industry, which has sparked renewed interest in the field among Americans and strong recruitment at the Pentagon's youngest branch.
"There is a ton of excitement across America on space in all sectors," said Gen. John Raymond, the U.S. Space Force's chief of operations, when asked by CNBC about the strides made by private space companies like Elon Musk's SpaceX.
"I've talked about people knocking on our door wanting to come into the Space Force in numbers greater than what we have slots to fill. I've talked in the past about how universities are seeing more students apply for space STEM degrees, which I think is going to be great for our nation," Raymond added.
"I'm excited about all of it, both what we're doing here on national security and what's going on in the commercial industry that we can leverage the advantage," the four-star general said without specifically naming any companies.
"The U.S. has always, has long understood that we are stronger with a secure and stable space domain and all of those sectors play into that," Raymond said.
The U.S. Space Force, the Pentagon's youngest branch, has increasingly looked to partner with the private sector as companies and investors pour into the space industry. The Pentagon is closely watching the progress of rocket builders like Rocket Lab, Astra and Virgin Orbit in addition to SpaceX.
Raymond's comments came on the heels of SpaceX announcing this week that it will fly its first all-civilian crew into orbit later this year, a mission known as Inspiration 4.
The landmark flight, led by billionaire Jared Isaacman, is aimed at using high-profile space tourism to raise support for St. Jude Children's Research Hospital. Three yet-to-be-announced passengers will accompany Isaacman on the multiday journey around the Earth, with two of the seats to be decided in public online competitions this month.
Raymond also called out NASA's Crew-1 mission, which was the first operational launch of SpaceX's Crew Dragon spacecraft.
"If you look at what's going on in the civil sector with the launch of U.S. astronauts, and in this last launch a Japanese astronaut from U.S. soil on a commercial launch vehicle, there's a ton of excitement there," he said.
Raymond did not provide a reaction to SpaceX's Starship rocket test flight on Tuesday, which resulted in an explosion as it attempted to land.
Starship prototype SN9 launched successfully to about 33,000 feet but, like the previous prototype flight in December, the rocket smashed into the ground while attempting to land.
Private investment in space companies last year set a fresh annual record, despite industry fears that the Covid-19 pandemic would end the past decade's momentum, according to a report by Space Capital last month. Builders of rockets and satellites brought in $8.9 billion in 2020, with venture capital and angel investors continuing to pour funds into space businesses.
Correction: A previous version of this story misquoted Gen. John Raymond. The story has been updated to reflect the correct quote.
CDC reverses indoor mask policy to recommend them for fully vaccinated people
Apple demolishes earnings expectations, but stock falls after iPhone chip supply warning
Housing boom is over as new home sales fall to pandemic low
Hobby Lobby's $1.6 million Gilgamesh tablet has been forfeited to the U.S.
U.S. sells one-of-a-kind Wu-Tang Clan album forfeited by 'pharma bro' Martin Shkreli